TW201334797A - 口腔護理組成物 - Google Patents
口腔護理組成物 Download PDFInfo
- Publication number
- TW201334797A TW201334797A TW101144898A TW101144898A TW201334797A TW 201334797 A TW201334797 A TW 201334797A TW 101144898 A TW101144898 A TW 101144898A TW 101144898 A TW101144898 A TW 101144898A TW 201334797 A TW201334797 A TW 201334797A
- Authority
- TW
- Taiwan
- Prior art keywords
- magnolol
- composition
- isobutyl
- butyl
- orally acceptable
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 114
- -1 isobutyl magnolol Chemical compound 0.000 claims abstract description 85
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 11
- 210000000214 mouth Anatomy 0.000 claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 239000002324 mouth wash Substances 0.000 claims description 8
- 229940051866 mouthwash Drugs 0.000 claims description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 239000000606 toothpaste Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 229940034610 toothpaste Drugs 0.000 claims description 5
- 208000007565 gingivitis Diseases 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 201000001245 periodontitis Diseases 0.000 claims description 3
- 206010006326 Breath odour Diseases 0.000 claims description 2
- 208000002925 dental caries Diseases 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 238000004383 yellowing Methods 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 16
- 239000000463 material Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 210000003296 saliva Anatomy 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003906 humectant Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 241000218378 Magnolia Species 0.000 description 5
- 239000003082 abrasive agent Substances 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000551 dentifrice Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000010455 vermiculite Substances 0.000 description 4
- 229910052902 vermiculite Inorganic materials 0.000 description 4
- 235000019354 vermiculite Nutrition 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002269 analeptic agent Substances 0.000 description 3
- 230000002272 anti-calculus Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000011180 diphosphates Nutrition 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 235000019204 saccharin Nutrition 0.000 description 3
- 229940081974 saccharin Drugs 0.000 description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N 2-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- VHSWSIMPWSWXKS-UHFFFAOYSA-N 2-[2-hydroxy-5-(2-methylpropyl)phenyl]-4-(2-methylpropyl)phenol Chemical compound CC(C)CC1=CC=C(O)C(C=2C(=CC=C(CC(C)C)C=2)O)=C1 VHSWSIMPWSWXKS-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- 239000004075 cariostatic agent Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- BYOBJKVGOIXVED-UHFFFAOYSA-N (2-phosphonoazepan-2-yl)phosphonic acid Chemical compound OP(O)(=O)C1(P(O)(O)=O)CCCCCN1 BYOBJKVGOIXVED-UHFFFAOYSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- RMSOEGBYNWXXBG-UHFFFAOYSA-N 1-chloronaphthalen-2-ol Chemical compound C1=CC=CC2=C(Cl)C(O)=CC=C21 RMSOEGBYNWXXBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FDVJJYZMLOZRGE-UHFFFAOYSA-N 4-butyl-2-(5-butyl-2-hydroxyphenyl)phenol Chemical compound CCCCC1=CC=C(O)C(C=2C(=CC=C(CCCC)C=2)O)=C1 FDVJJYZMLOZRGE-UHFFFAOYSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000045405 Astragalus penduliflorus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- ZSGJKBKUYXDVIE-UHFFFAOYSA-N CC(C)C[Mg] Chemical compound CC(C)C[Mg] ZSGJKBKUYXDVIE-UHFFFAOYSA-N 0.000 description 1
- JILFJFCGSUPHPA-UHFFFAOYSA-N CN1C(C1P(O)(=O)O)P(O)(=O)O Chemical compound CN1C(C1P(O)(=O)O)P(O)(=O)O JILFJFCGSUPHPA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940010556 ammonium phosphate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- ILZWGESBVHGTRX-UHFFFAOYSA-O azanium;iron(2+);iron(3+);hexacyanide Chemical compound [NH4+].[Fe+2].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] ILZWGESBVHGTRX-UHFFFAOYSA-O 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000007983 food acid Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 239000003912 lipotropic agent Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- FYNXOZOQSPWTPU-UHFFFAOYSA-N n,2,3-trimethyl-2-propan-2-ylbutan-1-amine Chemical compound CNCC(C)(C(C)C)C(C)C FYNXOZOQSPWTPU-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000009038 pharmacological inhibition Effects 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940045916 polymetaphosphate Drugs 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940045919 sodium polymetaphosphate Drugs 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/49—Solubiliser, Solubilising system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本發明係說明包含異丁基厚朴酚(isobutyl magnolol)及正丁基厚朴酚之口腔護理組成物,以及其製造及使用之方法。
Description
本發明係說明包含異丁基厚朴酚(isobutyl magnolol)及正丁基厚朴酚之口腔護理組成物,以及其製造及使用之方法。
使用於口腔護理組成物中之安全、有效的抗菌及抗發炎劑仍有需求。已知木蘭萃取物含有具抗菌及/或抗發炎性質之化合物,且使用此等化合物於口腔護理組成物中業已是相當大的興趣焦點。此等化合物於口腔護理組成物中之用途係說明於,例如,WO2001/085116、WO 2011/106492及WO 2011/106493中,該申請案之內容係合併於本文中作為參考。木蘭萃取物之各種組份的合成非天然類似物亦已知具有抗菌活性。異丁基厚朴酚(5,5'-二(2-甲基丙基)-聯苯基-2,2’-二醇)於口腔護理使用上為有希望的抗菌及抗發炎活性物。該化合物之合成,但非其口腔護理徵兆之用途者,係說明於WO2010/042313中。然而,異丁基厚朴酚於水及於油二者中之溶解度極端不良,且其於各種不同的界面活性劑系統中強烈傾向於由該組成物母質結晶出來,使其不利於使用於口腔護理配製物中。因此,仍需求於口腔上可接受且能夠溶解之異丁基厚朴酚使用於口腔護理組成物中。
現今令人驚奇地發現,添加正丁基厚朴酚至包含異丁基厚朴酚之組成物可大幅提高異丁基厚朴酚於該組成物中之溶解度。
並非藉由理論來束縛,吾等推測異丁基厚朴酚相較於其他類似物之不良的溶解度係由於其之高結晶能量。藉著與丁基厚朴酚混拌,其結晶出來之傾向明顯地降低。因此,該溶解度提高且攝取增加。本發明者業已發現當未添加共溶劑如丙二醇一辛酸酯時,異丁基厚朴酚與正丁基厚朴酚間最佳的混合比率為1:1。當添加丙二醇一酯,例如,丙二醇一辛酸酯時,最佳之比率變成3:1。亦報導丁基厚朴酚攝取之比較。於該配方中,隨著丁基厚朴酚之增加而攝取量增加。
於一個具體例中,因此,本發明係提供口腔護理組成物,例如包含異丁基厚朴酚及正丁基厚朴酚之牙膏,以及製造及使用此等組成物之方法。
本發明之適用性的其他領域可由下文所提供之詳細說明而變得顯而易見。應瞭解當指明本發明之較佳具體例時,該詳細的說明及特定之實例意欲用於闡明之目的且並非意欲限制本發明之範圍。
下列較佳具體例之說明僅性質上示範且絕非意欲用來限制本發明,其之應用,或用途。
於第一個具體例中,本發明係提供口腔護理組成物(組成物1),例如包含異丁基厚朴酚及正丁基厚朴酚之牙膏。例如,本發明係提供口腔護理組成物如下:
1.1.牙膏型式之組成物1;1.2.漱口劑型式之組成物1;1.3.任何前述之組成物,其中,該異丁基厚朴酚係以抗菌有效濃度存在;1.4.任何前述之組成物,其包含抗菌有效量之異丁基厚朴酚及可有效溶解異丁基厚朴酚於口腔上可接受之載體中的量之正丁基厚朴酚;1.5.任何前述之組成物,其中,異丁基厚朴酚之濃度以該組成物之總重量計,係由0.1-3%,例如,約0.5-2%;1.6.任何前述之組成物,其中,異丁基厚朴酚對正丁基厚朴酚按重量之比率係由1:3至3:1;1.7.任何前述之組成物,其中,異丁基厚朴酚對正丁基厚朴酚按重量之比率係約1:1;1.8.任何前述之組成物,其進一步包含丙二醇之脂肪酸一酯,例如,丙二醇一辛酸酯,例如,相對於異丁基厚朴酚及正丁基厚朴酚之總重量,按重量之比率為0.25:1至3:1,例如約1:1;1.9.任何前述之組成物,其進一步包含聚乙二醇,例如,PEG 600,例如,以0.5-5重量%之量;1.10.任何前述之組成物,其進一步包含濕潤劑,例如,甘油、山梨糖醇,或其混合物,例如,以約30%-70%,例如,40-60%,例如,約50重量%之量;1.11.任何前述之組成物,其進一步包含陰離子界面活性劑,例如,月桂基硫酸鈉,例如,以0.5-5%之量,例如,約2.5%;
1.12.任何前述之組成物,其進一步包含有效量之氟化物離子源,例如,氟化鈉,例如,以0.1-0.5重量%之量,例如,約0.34%;1.13.任何前述之組成物,其進一步包含調味劑,例如,選自於無熱量之甜味劑,例如,糖精、草本調味劑(例如,薄荷味),及其組合物;1.14.任何前述之組成物,其進一步包含研磨材料,例如,矽石研磨劑、沉澱碳酸鈣,或其組合物;1.15.任何前述之組成物,其包含下列之組成份:
本文中所用之“溶解有效量”一詞係指組成份之數量其有效於充分溶解存在於口腔上可接受之載體中之異丁基厚朴酚的數量。
於另外的具體例中,本發明係提供治療、預防或控制口腔之疾病或症狀,例如於口中細菌感染或發炎症狀,例如牙齦炎之方法,其包括施用根據本發明之口腔護理組成物,例如,組成物1,以及下列等,至需要其之病患之口腔。於某些具體例中,口腔之疾病或症狀包括牙齒、口腔黏膜、牙齦或舌頭之疾病或症狀。此等疾病或症狀包括齲齒、牙齦炎、牙周炎,及美容狀況如變黃及口臭。
於另外的具體例中,本發明係提供合併正丁基厚朴酚及異丁基厚朴酚於製造用於治療、預防或控制該口腔疾病或症狀之此等方法中之口腔護理組成物,例如,根據組成物1以及下列等的用途。
於另外的具體例中,本發明係提供製造口腔護理組成物,例如,根據組成物1以及下列等之方法,其包含將正丁基厚朴酚及異丁基厚朴酚與口腔上可接受之載體摻合。
本發明具體例之方法及組成物係藉由提供充分溶解性、安全且高度有效對抗哺乳類個體中之細菌感染及/或發炎的口腔組成物而賦予超過先前技藝組成物之優點。
厚朴酚(5,5'-二(丙-2-烯-1-基)-聯苯基-2,2'-二醇)為生物活性化合物,其係於厚朴(Houpu magnolia)(厚朴(Magnolia officinalis))之樹皮中發現。異丁基厚朴酚(5,5'-二(2-甲基丙基)-聯苯基-2,2’-二醇)為具有抗菌及抗發炎性質之厚朴酚合成類似物,其具有如下之結構:
正丁基厚朴酚(5,5'-二丁基-聯苯基-2,2’-二醇)為具有二個正丁基部分代替異丁基部分之類似化合物。
以“口腔上可接受的”意指以所需之含量安全使用於口中。通常,本發明組成物之所有的組份係口腔上可接受者。
如本說明書全文中所使用之"載體"或"水性載體"或"口腔上可接受之載體"表示法係指使用於本文中之任何安全及有效的材料。此等材料包括水、溶劑等,其可含有濕潤劑如甘油、山梨糖醇、木糖醇等。該載體或口腔上可接受之載體亦可包括另外的潔牙組份,如增稠劑(thickening agents)、離子活性組成份、緩衝劑、抗結石劑、研磨性拋光材料、過氧化物來源、鹼金屬碳酸氫鹽、界面活性劑、二氧化鈦、顏料、香料系統、甜化劑、抗微生物劑、草藥劑、去敏感劑、染色還原劑,及其混合物。
使用於本發明中之口腔上可接受之載體包括使用於製造牙膏、牙粉、預防性拋光膏(prophylaxis pastes)、漱口劑、含片、樹膠、小球體等中之習用及已知載體,且更充分地說明於下文中。較佳者為該口腔上可接受之載體不會引起刺激、腫脹或疼痛且典型地不會產生過敏或不良反應如胃部不適、噁心或頭暈。特定載體組份係依所想要之產物型式,包括潔牙劑、牙膏、牙粉、預防性拋光膏、漱口劑、含片、樹膠、凝膠、塗料、糕餅等而選擇。
本發明中"漱口劑"一詞係指口腔組成物其實質上適合於液體,如漱口水,噴霧劑,或漱洗劑。於此等製劑中,該口腔上可接受之載體典型地具有包含水或水及醇混合物之水相。再者,於各種具體例中,該口腔載體包括濕潤劑及界面活性劑如說明於下者。通常,水對醇之重量比係於1:1至20:1之量範圍內,較佳於3:1至10:1且更佳於4:1至6:1。於該類型之製劑中,水-醇混合物之總數量典型地係以該製劑之70至99.9%之量。於各種具體例中,該醇典型地為乙醇或異丙醇。
如精於此方面技藝之人士所公認者,本發明之口腔上可接受之載體亦可包含此方面技藝之人士所已知之各種其他習用活性組成份,包括抗噬菌斑劑、增白劑,抗菌劑、齒石控制(抗結石)劑、抗齲齒劑、敏感性劑等。較佳者,該載體實質上不會降低該異丁基厚朴酚之功效。
本發明之口腔組成物之此等液體及其他製劑之pH通常係4.5至10。該pH可用酸(例如,檸檬酸或苯甲酸)或鹼(例如,氫氧化鈉)或緩衝液(例如用檸檬酸鈉、苯甲酸鈉、碳酸鈉,或碳酸氫鈉、磷酸氫二鈉,或磷酸二氫鈉)予以控制。
於各種具體例中,該水性口腔組成物(例如,漱口劑)含有濕潤劑。該濕潤劑通常為濕潤劑之混合物,如甘油與山梨糖醇,及多元醇如己二醇,或聚乙二醇。雖然用聚乙二醇作為濕潤劑,除了提高活性組成份之溶解度外其之使用係可選擇的。於漱口劑時,該濕潤劑含量典型地係於5至40%且較佳於10至30%之範圍。
適合於本發明之組成物的界面活性劑係包括陰離子性、非離子性,及兩性離子的界面活性劑。該界面活性劑經常係以
0.01%至5%之量,較佳以0.5%至2.5%之量,存在於本發明之水性口腔組成物中。
根據本發明之口腔組成物可任意地包括其他材料,例如,清潔劑、增香劑、甜化劑、膠黏劑、界面活性劑、泡沫調節劑、研磨劑、pH改良劑、濕潤劑、保濕劑、口感劑、著色劑、研磨劑、防腐劑、氟化物離子源、唾液刺激劑、軟化劑、黏度改良劑、稀釋劑、乳化劑、營養物及其組合物。可添加至該口腔組成物之各種組份包括,例如,甜化劑如糖精或糖精鈉,醇如乙醇,氟化物離子源如氟化鈉,以及甘油,山梨糖醇,聚乙二醇,Poloxomer聚合物如POLOXOMER® 407、PLURONIC® F108,(二者可得自於BASF公司),烷基聚葡(APG),聚山梨酸酯,PEG40,蓖麻油,醇等。應了解,雖然上述材料類之各個一般屬性可能不同,但可能有一些共同的屬性且任何給定之材料可於此等材料分類之二種或多種內用於多重之目的上。較佳者,此等載體材料係經選擇與木蘭萃取物中所發現之活性組成份或其合成類似物,以及與該組成物之其他組成份相容。
那些有用於本文中之香料劑,其包括可操作以提高該組成物味道之任何材料或材料之混合物。任何口腔上可接受之天然或合成香料劑皆可使用,如香料油,香料醛、酯、醇、類似物質,及其組合物。香料劑係包括香草、鼠尾草、黑角蘭、歐芹油、綠薄荷油、肉桂油,鹿蹄草的油(水楊酸甲酯)、薄荷油、丁香油、月桂油、茴香油、桉樹油、柑橘油、果實油及香精包括那些由檸檬、柳橙、萊姆、葡萄柚、杏桃、香蕉、葡萄、蘋果、草莓、櫻桃、鳳梨等所導生者,由豆及堅果如咖啡、可可、可樂、花生、扁桃仁等所導生之香料,吸附性及包膠之香料劑,
及其混合物。亦涵括於本文中之香料劑為可於口中提供芳香及/或其他感官效果,包括清涼或溫熱效果之組成份。此等組成份包括醇、醋酸酯、乳酸酯、樟腦、桉樹油、桉樹腦、茴香腦、丁子香酚、山扁豆、歐沙酮(oxanone)、[α]-紫羅蘭酮、丙烯基癒瘡木酚(propenyl guaiethol)、百里酚、里哪醇、苯甲醛、肉桂醛、N-乙基-對-烷-3-羧胺、N,2,3-三甲基-2-異丙基丁醯胺、3-1-氧基丙烷-1,2-二醇、肉桂醛甘油縮醛(CGA)、薄荷酮(methone)甘油縮醛(MGA),及其混合物。一種或多種香料劑係任意地以0.01%至5%,任意於各種具體例中由0.05至2%,由0.1%至2.5%,及由0.1至0.5%之總量存在。
那些有用於本文中之甜化劑係包括右旋糖、多右旋糖、蔗糖、麥芽糖、糊精、乾性轉化糖、甘露糖、木糖、核糖、果糖、左旋糖、半乳糖、玉米糖漿、部分水解之澱粉、氫化澱粉水解產物、山梨糖醇、甘露糖醇、木糖醇、麥芽糖醇、異麥芽酮糖醇、阿斯巴甜(aspartame)、紐甜(neotame)、糖精及其鹽、蔗糖素(sucralose)、以二胜肽為底之強甜味劑、環己基磺醯銨酸鹽(cyclamates)、二氫查耳酮(dihydrochalcones),及其混合物。
口感劑係包括於使用本發明之組成物時賦予令人滿意之質地或其他感覺之材料。
那些有用於本文中之著色劑係包括顏料、染料、沉澱色料及增添特別光澤或反射性之試劑如珠光劑。於各種具體例中,著色劑可於牙齒表面上操作而提供白色或淺色塗層,其係於業已有效接觸該組成物之牙齒表面上作為位置之指示,及/或修改外觀,特別是該組成物之顏色及/或不透明度以增加對消費者之吸引力。任何口腔上可接受之著色劑皆可使用,包括FD&C染
料及顏料、滑石、雲母、碳酸鎂、碳酸鈣、矽酸鎂、矽酸鎂鋁、矽石、二氧化鈦、氧化鋅、紅色、黃色、褐色及黑色氧化鐵、氰亞鐵酸鐵銨(ferric ammonium ferrocyanide)、錳紫(manganese violet)、群青、鈦酸雲母、氯氧化鉍,及其混合物。一種或多種著色劑係任意地以0.001%至20%之總量存在,例如0.01%至10%或0.1%至5%。
於某些具體例中,本發明之口腔護理組成物可包含任意研磨劑,其係有用於,例如作為磨光劑。任何口腔上可接受之研磨劑皆可使用,但研磨劑之類型、細度、(粒子大小)及數量應予以選擇使得牙齒琺瑯質不會於該組成物之正常使用中過度磨損。適當之任意研磨劑係包括矽石,例如以沉澱矽石之型式或與礬土摻合、不溶性磷酸鹽、碳酸鈣,及其混合物。於不溶性磷酸鹽之中可用作為研磨劑者為正磷酸鹽、聚偏磷酸鹽及焦磷酸酯。闡明性之實例為正磷酸二鈣二水合物、焦磷酸鈣、焦磷酸鈣、磷酸三鈣、聚偏磷酸鈣及不溶性聚偏磷酸鈉。
於某些具體例中,本發明之組成物係任意地包含齒石控制(抗結石)劑。那些有用於本文中之齒石控制劑係包括此等試劑之任何鹽,例如其等之鹼金屬及銨鹽:磷酸鹽及聚磷酸鹽(例如焦磷酸酯)、聚胺基丙烷磺酸(AMPS)、聚烯烴磺酸鹽、聚烯烴磷酸鹽、二膦酸鹽如氮雜環烷-2,2-二膦酸鹽(例如,氮雜環庚烷-2,2-二膦酸)、N-甲基氮雜環戊烷-2,3-二膦酸、乙烷-1-羥基-1,1-二膦酸(EHDP)及乙烷-1-胺基-1,1-二膦酸鹽,及膦酸基鏈烷羧酸。有用的無機磷酸鹽及聚磷酸鹽包括一元、二元及三元磷酸鈉、三聚磷酸鈉、四聚磷酸鈉、焦磷酸一、二-、三-及四鈉、三偏磷酸鈉、六偏磷酸鈉及其混合物。
於其他具體例中,本發明之口腔組成物係任意地包含氟化物離子源,其係有用於,例如,作為抗齲齒劑。任何口腔上可接受之氟化物離子源皆可使用,包括氟化鉀、鈉及銨及一氟磷酸鹽,氟化亞錫,氟化銦,氟化胺如歐拉氟(olaflur)(N'-十八基三亞甲基二胺-N,N,N'-三(2-乙醇)-二氫氟化物),及其混合物。一種或多種氟化物離子源係任意地以提供臨床上有效量之可溶性氟化物離子至該口腔組成物之量存在。
於另外的具體例中,本發明之口腔組成物係任意地包含唾液刺激劑,其係有用於,例如,改善口乾。任何口腔上可接受之唾液刺激劑皆可使用,包括無需限制食物酸如檸檬酸、乳酸、蘋果酸、琥珀酸、抗壞血酸、己二酸、反式丁烯二酸及酒石酸,及其混合物。一種或多種唾液刺激劑係任意地以唾液刺激有效之總量存在。
於還有其他具體例中,本發明之口腔組成物係任意地包含營養物。適當之營養物包括維生素、礦物質、胺基酸,及其混合物。維生素包括維生素C及D、硫胺素、核黃素、泛酸鈣、菸鹼酸、葉酸、菸醯胺、吡哆醇、氰鈷胺、對-胺基苯甲酸、類生物黃鹼素(bioflavonoids),及其混合物。營養添加物包括胺基酸(如L-色胺酸、L-賴胺酸、蛋氨酸、蘇胺酸、左旋肉毒鹼(levocarnitine)及L-肉毒鹼)、肝營養素(lipotropics)(如膽鹼、肌醇、甜菜鹼,及亞麻油酸),及其混合物。
於某些具體例中,本發明係提供治療伴隨著口腔細菌存在之症狀的方法,其包括提供根據任何上述具體例之口腔組成物,且施用該口腔組成物至哺乳類個體之口腔。於某些具體例
中,該方法包括重複施用該組成物複數次直到於該個體中達到所想要之抗菌及/或抗發炎效果。
如本文中所指之口腔組織的"發炎"一般係指由組織之損傷或破壞所引起之局部性保護反應,其有用於破壞、稀釋,或隔離該有害試劑及受損組織二者。於急性發作型式中,其特徵在於疼痛、發熱、發紅、腫脹,及功能喪失。慢性發炎為緩慢的過程且主要特徴在於形成新的結締組織。慢性發炎經常為急性發炎之延續或為延長之低度發炎型式(如伴隨著牙周炎或牙齦炎)且通常導致永久性組織損傷。組織學上,發炎係涉及一系列複雜之事件,包括具有滲透性及血流量增加之動脈、毛細血管,及靜脈擴張;液體滲出,包括血漿蛋白質,且白血球位移至發炎位點。發炎係對應於提高之前發炎性細胞傳介物,或由細胞所釋放之物質的含量,例如,抗原與抗體相互作用或藉由抗原與致敏性淋巴細胞作用的結果。
於各種具體例中,施用或接觸係使用適當之敷料藉輕洗、塗佈、刷拭,或堆積成層而完成。於某些具體例中,接觸亦包括於進食或咀嚼中偶然發生之接觸。於各種具體例中,該組成物之施用包括使用有助於維持包含木蘭萃取物之抗發炎活性組成份對該標的組織達足夠長之接觸時間,以便提高一種或多種發炎傳介物,如PGE 2及TNF-α之生產藥理性抑制作用的施用設備。
於特定具體例中,口腔組成物並非故意吞嚥,而是保留於口腔中達一段足夠作用所意欲之效用的時間。於其他具體例中,特別那些當該口腔組成物係於動物產品,如寵物食品、寵物食品補充物(例如,治療),或咀嚼玩具中提供時,該口腔組成
物可以小的濃度攝入而不會對動物有害。較佳者,所要使用於本發明中之特定材料及組成物係製藥上或化妝品上可接受者。
如全文中所使用者,範圍係用簡略方式來說明該範圍內之各個及每一個數值。於該範圍內之任何數值可選擇作為該範圍之終點。此外,本文中所引證之所有的參考,其之全部內容係合併於本文中作為參考。萬一於本發明揭示內容中之定義與所引證之參考者發生衝突,則對照(controls)本發明之揭示內容。
除非另有指明,應瞭解於本文中及於本說明書中任何地方所表達之所有的百分比及數量係指重量百分比。所給定之數量係以該物質之活性重量計。
將具有異丁基厚朴酚及正丁基厚朴酚的組成物以1:3、1:1及3:1比率之不同組合如表1中所顯示者製備(如下):
IBM=異丁基厚朴酚
n-BM=正丁基厚朴酚
PGMC=丙二醇一辛酸酯
將來自於前面實例之10個組成物之樣品用於進行攝取至體外皮膚(Vitro-Skin)®試驗。Vitro-Skin®係為試驗的物質(可得自於IMS技術公司),其有效地模仿人類皮膚之表面特性。其含有最佳化之蛋白質且脂質組份且係設計成具有類似於人類皮膚之表面(topography)、pH、臨界表面張力及離子強度。
該攝取分析之實驗步驟如下:
1.將體外-皮膚(IMS公司,波特蘭,ME)切成直徑介於10至14毫米間之均勻小圓。可使用打孔器。需要確切之直徑以計算每平方厘米之攝取值。
2.為了移除該矽酮塗層,將該體外-皮膚小圓(散裝)用己烷沖洗5分鐘達三次。空氣乾燥以蒸發己烷。
3.將體外-皮膚於拋棄式聚苯乙烯之尖底離心管中之經殺菌且澄清的唾液浸泡過夜。每個組織使用1毫升唾液。各執行一式三份。
4.吸出唾液,添加1毫升1:2之糊漿且培育於37ºC水浴中達2分鐘。迅速操作,由於攝取係依於各種溫度下之曝露時間而定。
5.將該生漿吸出且用5毫升去離子水沖洗三次每次10秒鐘。使用渦動沖洗(最大速度)。將該組織轉移至新的聚苯乙烯尖底離心管中。迅速操作且以相同之速度下處理所有的樣品。
6.添加1毫升乙醇且充分萃取該活性物(渦動或振盪至少1小時)。該體外-皮膚不溶於乙醇中。
7.將該萃取物轉移至HPLC小瓶中且使用於該特定活性物之適當條件進行HPLC分析。所得到之活性物的含量(典型地以微克/毫升計)數值上等於每組織之微克數(UT)。
8.使用下列之公式來計算每平方厘米活性物之攝取值:UR=2*UT/(π *d2)[微克/厘米2]其中:UR 為(相對)體外-皮膚(兩面)每平方厘米活性物之攝取值UT 為每組織之活性物之攝取值π 為3.14159…d 為該組織之直徑,以厘米計。
於體外-皮膚®分析中,異丁基厚朴酚及正丁基厚朴酚於實例1之10個組成物之平均攝取的數據列於表2中(於下):
由此等數據可看出,於異丁基厚朴酚之最佳的吸收係當異丁基厚朴酚對丁基厚朴酚之比率為1:1時(組成物3)。即使於組成物3中異丁基厚朴酚之絕對數量僅為0.7%,於組成物1中為1.4%之一半,對該體外-皮膚之攝取值於組成物3時明顯地比於組成物1者高,顯示出正丁基厚朴酚之存在促進該異丁基厚朴酚之攝取。當該丙二醇一辛酸酯存在時,異丁基厚朴酚對丁基厚朴酚之最佳比率改變成3:1(組成物7)。然而令人驚奇的,最好的結果係不含丙二醇酯共界面活性劑所得到者,如由組成物1及6,2及7,3及8,及4及9間之不同看出者。
異丁基厚朴酚對體外-皮膚之攝取提高係由本發明者所發現且藉於上表中之數據說明-當將正丁基厚朴酚加至含有異丁基厚朴酚之組成物時,顯示正丁基厚朴酚提高異丁基厚朴酚於本文中所說明之組成物中之溶解度的能力。
Claims (11)
- 一種口腔護理組成物,其包含:異丁基厚朴酚(magnolol);正丁基厚朴酚;及口腔上可接受之載體;其中,正丁基厚朴酚係以有效溶解異丁基厚朴酚於該口腔上可接受之載體中之量存在。
- 如申請專利範圍第1項之組成物,係為牙膏型式。
- 如申請專利範圍第1項之組成物,係為漱口劑型式。
- 如前述申請專利範圍中任一項之組成物,其中,該異丁基厚朴酚係以抗菌有效量存在。
- 如前述申請專利範圍中任一項之組成物,其中,該異丁基厚朴酚以該組成物之總重量計,係以自約0.1%至約3%之量存在。
- 如前述申請專利範圍中任一項之組成物,其中,異丁基厚朴酚對正丁基厚朴酚按重量之比率係自約3:1至約1:3。
- 如前述申請專利範圍中任一項之組成物,其中,該口腔上可接受之載體包含另外的組成份,其係選自於:聚乙二醇、濕潤劑、陰離子界面活性劑、丙二醇之脂肪酸一酯、有效量之氟化物離子源、調味劑、研磨劑,及其二種或多種之組合物。
- 如前述申請專利範圍中任一項之組成物,其包含下列按重量之成份:
- 一種治療、預防或控制口腔之疾病或症狀的方法,其包含施用如前述申請專利範圍中任一項之組成物至需要其之病患的口腔。
- 如申請專利範圍第9項之方法,其中,該口腔之疾病或症狀係選自於齲齒、牙齦炎、牙周炎、牙齒變黃及口臭。
- 一種提高含有異丁基厚朴酚之口腔護理組成物之溶解度的方法,其包含將溶解有效量之正丁基厚朴酚與包含異丁基厚朴酚之口腔上可接受之載體摻合。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/063031 WO2013081627A1 (en) | 2011-12-02 | 2011-12-02 | Oral care compositions comprising n-butyl magnolol and isobutyl magnolol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201334797A true TW201334797A (zh) | 2013-09-01 |
Family
ID=45316141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101144898A TW201334797A (zh) | 2011-12-02 | 2012-11-30 | 口腔護理組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9370475B2 (zh) |
| EP (1) | EP2793812A1 (zh) |
| JP (1) | JP2015500233A (zh) |
| CN (1) | CN103957870B (zh) |
| AR (1) | AR089061A1 (zh) |
| AU (1) | AU2011382469B2 (zh) |
| BR (1) | BR112014013183A2 (zh) |
| CA (1) | CA2856823A1 (zh) |
| MX (1) | MX345779B (zh) |
| PH (1) | PH12014501136A1 (zh) |
| RU (1) | RU2014126824A (zh) |
| SG (1) | SG11201402060RA (zh) |
| TW (1) | TW201334797A (zh) |
| WO (1) | WO2013081627A1 (zh) |
| ZA (1) | ZA201403810B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201402059RA (en) | 2011-12-02 | 2014-09-26 | Colgate Palmolive Co | Oral care composition comprising isobutyl magnolol |
| US12311044B2 (en) | 2018-12-18 | 2025-05-27 | Conopco, Inc. | Antimicrobial composition |
| CN113226262B (zh) | 2018-12-21 | 2023-10-31 | 联合利华知识产权控股有限公司 | 包含改性黏土和共聚物的抗菌组合物 |
| CN114983879B (zh) * | 2022-07-20 | 2023-12-01 | 成都中医药大学 | 一种厚朴酚漱口水及其制备方法 |
| WO2025043334A1 (en) * | 2023-08-25 | 2025-03-06 | U Corp. | Composition for supplemental oral hygiene |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0733649A (ja) * | 1993-07-19 | 1995-02-03 | Kanebo Ltd | 抗う蝕剤 |
| WO2001082922A1 (en) | 2000-04-27 | 2001-11-08 | The Procter & Gamble Company | Oral compositions comprising polyphenol herbal extracts |
| US6500409B1 (en) | 2000-05-10 | 2002-12-31 | Colgate Palmolive Company | Synergistic antiplaque/antigingivitis oral composition |
| EP1761271B1 (en) * | 2004-06-18 | 2008-12-03 | Symrise GmbH & Co. KG | Blackberry extract |
| US20060127329A1 (en) * | 2004-12-10 | 2006-06-15 | Colgate-Palmolive Company | Tartar control oral care composition containing extract of magnolia |
| US8071077B2 (en) * | 2004-12-29 | 2011-12-06 | Colgate-Palmolive Company | Oral compositions containing biphenol antibacterial compounds |
| JP4685716B2 (ja) | 2006-06-27 | 2011-05-18 | 花王株式会社 | 美白化粧料 |
| JP4685719B2 (ja) | 2006-06-27 | 2011-05-18 | 花王株式会社 | 美白化粧料 |
| CN102177171B (zh) | 2008-10-08 | 2014-02-12 | 陶氏技术投资有限公司 | 合成二亚磷酸酯的淤浆方法 |
| TWI422382B (zh) * | 2010-02-24 | 2014-01-11 | Colgate Palmolive Co | 加強木蘭活性物之溶解度及傳送的組成物 |
| TWI459957B (zh) * | 2010-02-24 | 2014-11-11 | Colgate Palmolive Co | 口腔保健組成物 |
| DE102010015789A1 (de) * | 2010-04-20 | 2011-10-20 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen enthaltend Kombinationen aus Magnolienrindenextrakt und Alkylsulfaten |
| SG11201402059RA (en) | 2011-12-02 | 2014-09-26 | Colgate Palmolive Co | Oral care composition comprising isobutyl magnolol |
-
2011
- 2011-12-02 CN CN201180075237.0A patent/CN103957870B/zh not_active Expired - Fee Related
- 2011-12-02 MX MX2014006578A patent/MX345779B/es active IP Right Grant
- 2011-12-02 EP EP11794375.3A patent/EP2793812A1/en not_active Ceased
- 2011-12-02 SG SG11201402060RA patent/SG11201402060RA/en unknown
- 2011-12-02 US US14/360,049 patent/US9370475B2/en active Active
- 2011-12-02 BR BR112014013183A patent/BR112014013183A2/pt not_active Application Discontinuation
- 2011-12-02 WO PCT/US2011/063031 patent/WO2013081627A1/en not_active Ceased
- 2011-12-02 CA CA2856823A patent/CA2856823A1/en not_active Abandoned
- 2011-12-02 AU AU2011382469A patent/AU2011382469B2/en not_active Ceased
- 2011-12-02 JP JP2014544713A patent/JP2015500233A/ja active Pending
- 2011-12-02 RU RU2014126824A patent/RU2014126824A/ru not_active Application Discontinuation
-
2012
- 2012-11-30 AR ARP120104527A patent/AR089061A1/es unknown
- 2012-11-30 TW TW101144898A patent/TW201334797A/zh unknown
-
2014
- 2014-05-21 PH PH12014501136A patent/PH12014501136A1/en unknown
- 2014-05-23 ZA ZA2014/03810A patent/ZA201403810B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2856823A1 (en) | 2013-06-06 |
| ZA201403810B (en) | 2016-04-28 |
| AU2011382469B2 (en) | 2015-06-11 |
| JP2015500233A (ja) | 2015-01-05 |
| AU2011382469A1 (en) | 2014-05-22 |
| EP2793812A1 (en) | 2014-10-29 |
| WO2013081627A1 (en) | 2013-06-06 |
| MX2014006578A (es) | 2014-08-21 |
| SG11201402060RA (en) | 2014-09-26 |
| MX345779B (es) | 2017-02-15 |
| RU2014126824A (ru) | 2016-01-27 |
| BR112014013183A2 (pt) | 2017-06-13 |
| CN103957870A (zh) | 2014-07-30 |
| AR089061A1 (es) | 2014-07-30 |
| US9370475B2 (en) | 2016-06-21 |
| US20140314688A1 (en) | 2014-10-23 |
| PH12014501136A1 (en) | 2014-07-28 |
| CN103957870B (zh) | 2016-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI459957B (zh) | 口腔保健組成物 | |
| TWI422382B (zh) | 加強木蘭活性物之溶解度及傳送的組成物 | |
| TWI442938B (zh) | 口腔護理組成物 | |
| TW201334797A (zh) | 口腔護理組成物 | |
| TWI458500B (zh) | 口腔保健組成物及方法 | |
| TWI471129B (zh) | 口腔護理組成物 |